CNS tuberculoma in an immunocompetent patient: A case report of multi-drug hypersensitivity to RIPE therapy
Background: Tuberculosis (TB) is the second leading cause of death due to an infectious disease worldwide (World Health Organization, 2022 [1]). The first line treatment of TB involves the concurrent use of four drugs: rifampin, isoniazid, pyrazinamide, and ethambutol (RIPE). Given the rising threat...
| Auteurs principaux: | , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Elsevier
2023-01-01
|
| Collection: | IDCases |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S221425092300210X |